Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30710203 | 1.00 | THRB (0.48) | THRBALDH1A1EPHX1TDP1TSHR | |
| SCHEMBL15560285 | 0.92 | THRB (0.42) | THRBALDH1A1EPHX1DNM1 | |
| SCHEMBL18944397 | 0.86 | THRB (0.36) | THRB | |
| SCHEMBL2101563 | 0.85 | EPHX1 (0.41) | THRBALDH1A1EPHX1DNM1CA2 | |
| SCHEMBL20145830 | 0.83 | ALDH1A1 (0.39) | THRBALDH1A1EPHX1TDP1 | |
| SCHEMBL10529314 | 0.83 | THRB (0.36) | THRB | |
| SCHEMBL15187792 | 0.83 | THRB (0.36) | THRB | |
| SCHEMBL25086738 | 0.83 | EPHX1 (0.42) | THRBALDH1A1EPHX1TSHRDNM1 | |
| SCHEMBL21689831 | 0.83 | EPHX1 (0.42) | THRBALDH1A1EPHX1TSHRDNM1 | |
| SCHEMBL2103885 | 0.83 | EPHX1 (0.42) | THRBALDH1A1EPHX1TSHRDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2024-02-15 | — | — | US | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| EP-4096618-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2022-12-07 | — | — | EP | claimed |
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| WO-2022122143-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| EP-2555742-B2 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2018-12-05 | — | — | EP | claimed |
| US-10113140-B2 | Freshening compositions and devices comprising same | THE PROCTER & GAMBLE COMPANY (US) | 2018-10-30 | — | — | US | claimed |
| US-9023783-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2015-05-05 | — | — | US | claimed |
| US-20140342969-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2014-11-20 | — | — | US | claimed |
| US-8822402-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-02 | — | — | US | claimed |
| US-8633148-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2014-01-21 | — | — | US | claimed |
| EP-2555742-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2013-02-13 | — | — | EP | claimed |
| EP-2556139-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2013-02-13 | — | — | EP | claimed |
| WO-2011127030-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-13 | — | — | WO | claimed |
| WO-2011127011-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-13 | — | — | WO | claimed |
| US-20110245134-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2011-10-06 | — | — | US | claimed |
| US-20110245136-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2011-10-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | OR10J3, OR51E2, MAL2 | THRB 3399/4885ALDH1A1 27/4885EPHX1 1836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.